Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall is a rigid structure surrounding bacterial cells, primarily composed of peptidoglycan, which provides osmotic protection and defines cell shape. Gram-positive bacteria have thick peptidoglycan layers, often with teichoic acids, while Gram-negative bacteria have thinner peptidoglycan and an additional outer membrane. The fungal cell wall is a multilayered structure composed mainly of chitin, β-glucans, and glycoproteins, conferring rigidity, protection, and determining morphology. Both cell wall types are essential for microbial viability and are absent in mammalian cells, making their biosynthetic enzymes prime targets for antimicrobial drugs. Disruption of these walls leads to cell death, and various antibiotics and antifungal drugs act specifically by inhibiting the synthesis of their respective wall components[1][2][3][5][6].
Inhibition of peptidoglycan synthesis (bacteria: e.g., β-lactams); Inhibition of chitin or glucan synthesis (fungi: echinocandins inhibit β-1,3-glucan synthase); Disruption of cell wall structure and integrity, causing cell lysis
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and fungal cell wall.